 
        
        
        Rhapontigenin是从 Rheum undulatum 根茎中提取的白藜芦醇天然类似物,具有抗氧化、抗真菌、抗菌和抗癌活性。它是强效细胞色素 P450 1A1 抑制剂,IC50 为 400 nM,对 P450 1A2 和 P450 1B1 的选择性分别高 400 倍和 23 倍。此外,它可抑制 PI3K 依赖的 Rac1 信号通路,从而抑制肿瘤迁移和侵袭。
 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 描述 | Rhapontigenin, a natural product isolated and purified from the rhizomes of Rheum undulatum with antioxidative, antihyperlipidemic, and antifungal activities, inhibits tyrosinase activity and melanin synthesis in B16F10 melanoma cells and HIF-1α accumulation and angiogenesis in PC-3 prostate cancer cells, suppresses breast cancer cell migration and invasion, which is involved in inhibiting the PI3K-dependent Rac1 signaling pathway. | 
| Concentration | Treated Time | Description | References | |
| HeLa cells | 20 µM | 24 hours | Enhanced co-localization of mitochondria with lysosomes | Nat Biomed Eng. 2022 Jan;6(1):76-93 | 
| HeLa cells | 10 µM | 24 hours | Induced mitophagy | Nat Biomed Eng. 2022 Jan;6(1):76-93 | 
| Human pulmonary artery endothelial cells (HPAEC) | 5 µM | 1-hour pretreatment | Inhibition of CYP1A1 activity attenuated MRSA-induced EC permeability and inflammatory responses | FASEB J. 2024 Nov 30;38(22):e70205 | 
| Human lung microvascular endothelial cells (HLMVEC) | 5 µM | 1-hour pretreatment | Inhibition of CYP1A1 activity attenuated MRSA-induced EC permeability and inflammatory responses | FASEB J. 2024 Nov 30;38(22):e70205 | 
| Mouse peritoneal macrophages | 10 µM | 2 hours | Rhapontigenin treatment increased the expression level of SR-A and enhanced bacterial phagocytosis in E.coli-treated mouse peritoneal macrophages. | Cell Commun Signal. 2020 May 4;18(1):70 | 
| RAW264.7 cells | 10 µM | 2 hours | Rhapontigenin pre-treatment reduced the expression levels of TNF-α and IL-6 in LPS-stimulated RAW264.7 cells. | Cell Commun Signal. 2020 May 4;18(1):70 | 
| HeLa cells | 20, 40, 80 µM | 24 hours | Reduced the expression of the mitochondrial outer membrane protein MFN2 and mitochondrial inner membrane protein Tim23 | Nat Biomed Eng. 2022 Jan;6(1):76-93 | 
| Pectobacterium carotovorum subsp. carotovorum | 156 µg/mL | 24 hours | Assessment of Rhapontigenin's inhibitory effects on motility, EPS production, biofilm formation, and virulence exoenzyme synthesis, showing significant inhibition at 1/2 MIC concentration. | Molecules. 2022 Dec 14;27(24):8878 | 
| Chromobacterium violaceum CV026 | 78 µg/mL | 24 hours | Evaluation of Rhapontigenin as a quorum sensing inhibitor on violacein production inhibition, showing 59.55% inhibition at 1/2 MIC concentration. | Molecules. 2022 Dec 14;27(24):8878 | 
| MDA-MB-231 cells | 5-50 µM | 24 hours | To evaluate the cytotoxic effects of Rhapontigenin, which showed weak effects on MDA-MB-231 cell viability | Molecules. 2018 May 18;23(5):1215 | 
| MCF-7 cells | 5-50 µM | 24 hours | To evaluate the cytotoxic effects of Rhapontigenin, which showed a concentration-dependent decrease in MCF-7 cell viability | Molecules. 2018 May 18;23(5):1215 | 
| SH-SY5Y cells | 10 µM | 3 and 6 days | To evaluate the stimulatory effect of RHA on neurite outgrowth in SH-SY5Y cells. Results showed that RHA at 10 μM significantly stimulated neurite outgrowth with a significant difference compared to the control (p < 0.001). | Antioxidants (Basel). 2023 Jun 29;12(7):1362 | 
| Human colorectal cancer cells Caco-2 | 25, 50, 100 µM | 48 hours | To evaluate the cytotoxicity of Rhapontigenin and its analogues against colon cancer cells. Results showed that Rhapontigenin exhibited the strongest cytotoxicity at 100 µM, with a cell survival rate of 32%. | Biomolecules. 2023 Aug 20;13(8):1270 | 
| MCF-7 cells | 5-50 µM | 6 days | To evaluate the estrogen-like activity of Rhapontigenin, which showed a concentration-dependent increase in MCF-7 cell proliferation | Molecules. 2018 May 18;23(5):1215 | 
| Administration | Dosage | Frequency | Description | References | ||
| Caenorhabditis elegans | Transgenic nematodes with pan-neuronal expression of human Aβ1–42 (hAβ1–42) | Supplemented in the medium | 0.2 mM | From egg hatching onwards | Improved learned behavioural performance | Nat Biomed Eng. 2022 Jan;6(1):76-93 | 
| C57BL/6 male mice | MRSA-induced acute lung injury model | Intraperitoneal (IP) | 10 mg/kg | Single dose, 18-hour duration | Improved multiple indices of MRSA-induced ALI, including BAL protein concentration, cytokine levels, and markers of endothelial damage | FASEB J. 2024 Nov 30;38(22):e70205 | 
| C57BL/6 mice | CLP or E.coli-induced sepsis model | Intraperitoneal injection | 2.5 mg/kg, 5 mg/kg and 10 mg/kg | Single injection, survival monitored for 2 days | Rhapontigenin improved the survival rate of mice in CLP or E.coli-induced sepsis, reduced the levels of inflammatory biomarkers (TNF-α, IL-6, 12(S)-HETE, ALT and AST), and enhanced bacterial clearance. | Cell Commun Signal. 2020 May 4;18(1):70 | 
| Zebrafish | Type 2 diabetes model | Intraperitoneal injection | 2.5-100 mg/kg | 6 days | Improved insulin resistance by regulating the PI3K/AKT/mTOR signaling pathway, reduced blood glucose, TC, TG, and LDL-C levels, and increased HDL-C levels | Heliyon. 2024 Jun 14;10(13):e32007 | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 3.87mL 0.77mL 0.39mL | 19.36mL 3.87mL 1.94mL | 38.72mL 7.74mL 3.87mL | |
| CAS号 | 500-65-2 | 
| 分子式 | C15H14O4 | 
| 分子量 | 258.27 | 
| SMILES Code | OC1=CC(/C=C/C2=CC=C(OC)C(O)=C2)=CC(O)=C1 | 
| MDL No. | MFCD00017718 | 
| 别名 | Protigenin | 
| 运输 | 蓝冰 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C | 
| 溶解方案 | DMSO: 120 mg/mL(464.63 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1